Biofrontera AG BFRA

Biofrontera AG Betriebsaufwand 2011-2026 | BFRA

Betriebsaufwand Jährlich Biofrontera AG

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
34.4 M	49.8 M	35.1 M	24.2 M	16.3 M	13.1 M	11.5 M	8.65 M	5.48 M	4.44 M

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
49.8 M	4.44 M	20.3 M

Betriebsaufwand anderer Aktien in der Pharmaeinzelhändler

Name	Betriebsaufwand	Preis	% 24h	Marktkapitalisierung	Land
FSD Pharma HUGE	15.3 M	-	5743.5 %	$ 69.7 M	Canada
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Happiness Biotech Group Limited HAPP	6.79 M	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	226 M	-	-	$ 2.18 B	USA
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
BioNTech SE BNTX	512 M	$ 89.59	-	$ 21.7 B	Germany
Compugen Ltd. CGEN	32.2 M	$ 2.22	-	$ 207 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Coherus BioSciences CHRS	231 M	$ 1.58	-	$ 185 M	USA
Athira Pharma ATHA	18.7 M	-	-	$ 269 M	USA
BiondVax Pharmaceuticals Ltd. BVXV	78.4 M	-	0.74 %	$ 768 M	Israel
Abcam plc ABCM	170 M	-	-	$ 4.9 B	Britain
Galera Therapeutics GRTX	70.6 M	-	-32.59 %	$ 7.61 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Affimed N.V. AFMD	54 M	-	-34.95 %	$ 21.5 M	Germany
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Checkmate Pharmaceuticals CMPI	61.5 M	-	-	$ 231 M	USA
Celyad Oncology SA CYAD	26.2 M	-	-	$ 12.5 M	Belgium
Berkeley Lights BLI	152 M	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	58.1 M	$ 29.93	-	$ 1.99 B	USA
Generation Bio Co. GBIO	162 M	-	-	$ 344 M	USA
IMV IMV	35.1 M	-	-	$ 13.1 M	Canada
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Enlivex Therapeutics Ltd. ENLV	15 M	$ 0.79	-	$ 36.1 M	Israel
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Esperion Therapeutics ESPR	343 M	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	43.6 M	$ 28.9	-	$ 778 M	USA
Cyclacel Pharmaceuticals CYCCP	9.17 M	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	98.4 M	-	-	$ 384 M	Britain
Forte Biosciences FBRX	70.7 M	$ 16.69	-	$ 216 M	USA
Gracell Biotechnologies GRCL	214 M	-	-	$ 3.37 B	China
Anika Therapeutics ANIK	51.6 M	$ 14.79	-	$ 212 M	USA
Advaxis ADXS	19.6 M	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	13.3 M	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	10.4 M	$ 3.16	-	$ 5.2 M	Israel
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
CRISPR Therapeutics AG CRSP	668 M	$ 56.95	-	$ 5.12 B	Schweiz
Aptinyx APTX	62.6 M	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Galectin Therapeutics GALT	20.1 M	$ 2.38	-	$ 152 M	USA